+ All Categories
Home > Documents > ENDOCRINE DISRUPTORS: THE EU REGULATORY...

ENDOCRINE DISRUPTORS: THE EU REGULATORY...

Date post: 10-Oct-2020
Category:
Upload: others
View: 5 times
Download: 0 times
Share this document with a friend
15
ENDOCRINE DISRUPTORS: THE EU REGULATORY FRAMEWORK Ladislav Miko, SANTE Brussels, 1 st June 2015
Transcript
Page 1: ENDOCRINE DISRUPTORS: THE EU REGULATORY FRAMEWORKec.europa.eu/health/sites/health/files/endocrine... · ED is "approval criterion" (strong hazard component) Art. 4.7 derogation in

ENDOCRINE DISRUPTORS:

THE EU REGULATORY FRAMEWORK

Ladislav Miko, SANTE

Brussels, 1st June 2015

Page 2: ENDOCRINE DISRUPTORS: THE EU REGULATORY FRAMEWORKec.europa.eu/health/sites/health/files/endocrine... · ED is "approval criterion" (strong hazard component) Art. 4.7 derogation in

Outline

EU legislation on endocrine disruptors (EDs)

Regulation on Plant Protection Products and Biocidal products + criteria to identify EDs

The Impact Assessment

Page 3: ENDOCRINE DISRUPTORS: THE EU REGULATORY FRAMEWORKec.europa.eu/health/sites/health/files/endocrine... · ED is "approval criterion" (strong hazard component) Art. 4.7 derogation in

Specific provisions on EDs

Water Framework Directive (2000)

REACH Regulation (2006)

Regulation on Plant Protection Products (2009)

Regulation on Cosmetics (2009)

Regulation on Biocidal Products (2012)

Page 4: ENDOCRINE DISRUPTORS: THE EU REGULATORY FRAMEWORKec.europa.eu/health/sites/health/files/endocrine... · ED is "approval criterion" (strong hazard component) Art. 4.7 derogation in

Adverse effects caused by EDs already covered by "standard" risk

assessments

Chemicals (REACH) Plant protection products Biocidal products Cosmetics Workers legislation Food Contact Materials Toys Medical Devices ....

Page 5: ENDOCRINE DISRUPTORS: THE EU REGULATORY FRAMEWORKec.europa.eu/health/sites/health/files/endocrine... · ED is "approval criterion" (strong hazard component) Art. 4.7 derogation in

Outside EU: no criteria to identify EDs for regulatory purposes

EU legislation: already high protection from EDs to human health & environment

Page 6: ENDOCRINE DISRUPTORS: THE EU REGULATORY FRAMEWORKec.europa.eu/health/sites/health/files/endocrine... · ED is "approval criterion" (strong hazard component) Art. 4.7 derogation in

Regulations on Plant Protection Products

& on Biocidal Products

Page 7: ENDOCRINE DISRUPTORS: THE EU REGULATORY FRAMEWORKec.europa.eu/health/sites/health/files/endocrine... · ED is "approval criterion" (strong hazard component) Art. 4.7 derogation in

Regulatory consequences for EDs already defined

Interim criteria to identify EDs set

New criteria required by end 2013

Page 8: ENDOCRINE DISRUPTORS: THE EU REGULATORY FRAMEWORKec.europa.eu/health/sites/health/files/endocrine... · ED is "approval criterion" (strong hazard component) Art. 4.7 derogation in

Regulatory consequences for EDs

PPP ED is "approval criterion" (strong hazard component)

Art. 4.7 derogation in case of serious danger to plant health

BP Professional use: (strong risk component + Art 5.2

derogation for disproportionate negative impact on society)

Consumer use: hazard-based non-approval

Page 9: ENDOCRINE DISRUPTORS: THE EU REGULATORY FRAMEWORKec.europa.eu/health/sites/health/files/endocrine... · ED is "approval criterion" (strong hazard component) Art. 4.7 derogation in

High political attention on criteria to identify EDs

Council Conclusions (2012)

European Parliament Resolution (2013)

7th EAP (2013)

• Horizontal criteria

• Impact assessment

Page 10: ENDOCRINE DISRUPTORS: THE EU REGULATORY FRAMEWORKec.europa.eu/health/sites/health/files/endocrine... · ED is "approval criterion" (strong hazard component) Art. 4.7 derogation in

Studies/Opinions requested

• Kortenkamp Report (2011)

• EFSA Opinion (2013)

• JRC Expert Advisory Group Report (2013)

2009-2013: COM work for developing criteria

Page 11: ENDOCRINE DISRUPTORS: THE EU REGULATORY FRAMEWORKec.europa.eu/health/sites/health/files/endocrine... · ED is "approval criterion" (strong hazard component) Art. 4.7 derogation in

Activities • Ad-hoc WG (lead by DG ENV)

• ED Expert Advisory Group (lead by JRC)

• COM Conference 2012

• 1st draft for criteria:

o discussed in the Ad-hoc WG

o consensus not reached

o formal COM Inter-Service Consultation did not start

2009-2013: COM work for developing criteria

Page 12: ENDOCRINE DISRUPTORS: THE EU REGULATORY FRAMEWORKec.europa.eu/health/sites/health/files/endocrine... · ED is "approval criterion" (strong hazard component) Art. 4.7 derogation in

Science divergences

Criteria to identify EDs likely to impact other sectors

Regulatory consequences vary across sectors (decision making based on hazard/risk/risk-benefit)

Significant impacts expected depending on criteria and sectors

Different legal procedures to implement criteria

Complexity

Page 13: ENDOCRINE DISRUPTORS: THE EU REGULATORY FRAMEWORKec.europa.eu/health/sites/health/files/endocrine... · ED is "approval criterion" (strong hazard component) Art. 4.7 derogation in

2013 start of an Impact Assessment

Page 14: ENDOCRINE DISRUPTORS: THE EU REGULATORY FRAMEWORKec.europa.eu/health/sites/health/files/endocrine... · ED is "approval criterion" (strong hazard component) Art. 4.7 derogation in

Impact Assessment well on track

..more details in next presentations

Page 15: ENDOCRINE DISRUPTORS: THE EU REGULATORY FRAMEWORKec.europa.eu/health/sites/health/files/endocrine... · ED is "approval criterion" (strong hazard component) Art. 4.7 derogation in

Recommended